Online public interest in common malignancies and cancer screening during the COVID-19 pandemic in the United States
Background and Aim: The COVID-19 pandemic was declared a national emergency in the United States in March 2020. The Centers for Medicare and Medicaid Services subsequently released recommendations
that health-care facilities temporarily delay elective surgeries and non-essential medical procedures. Disruptions to medical care significantly impacted cancer patients, with cancer screenings halted and nonurgent cancer surgeries postponed as health-care facilities shifted resources toward the COVID-19 pandemic. Although it has been reported that cancer screening rates decreased dramatically in the United
States in 2020, it is unclear whether this trend was driven by factors related to public interest in cancer and/ or cancer screening as opposed to other factors such as clinical backlogs, pandemic-related policies, and/or resource limitations. The purpose of this study was to use the Google Trends tool to evaluate public interest in six common malignancies and four common cancer screening methods during the COVID-19 pandemic.
Methods: We used the Google Trends tool to quantify public interest in six different malignancies (Breast Cancer, Colon Cancer, Lung Cancer, Prostate Cancer, Thyroid Cancer, and Cervical Cancer) and four cancer screening methods (Pap Smear, Lung Cancer Screening, Mammogram, and Colonoscopy) in the United States during the COVID-19 pandemic. Welch’s t-tests were used to compare monthly search volumes during the COVID-19 pandemic (2020) to the 4 years before the pandemic (2016 – 2019) for all ten search terms included in our study. We used Benjamini-Hochberg to adjust raw p values to account for multiple statistical comparisons. The level of statistical significance was defined by choosing a false discovery rate of 0.05.
Results: Our results indicate significantly reduced interest in all malignancies studied at the beginning of the COVID-19 pandemic. Public interest in [‘Breast Cancer’], [‘Colon Cancer’], [‘Lung Cancer’],
[‘Thyroid Cancer’], and [‘Cervical Cancer’] significantly decreased in the months of March, April, May, and June 2020 when compared with public interest in 2016-2019. Public interest in cancer screening methods such as [‘Pap Smear’], [‘Lung Cancer Screening’], [‘Mammogram’], and [‘Colonoscopy’] significantly deceased in the months of April and May compared to 2016 – 2019 values. However, decreased public interest in cancer screening methods was temporary, with Google search volumes returning to pre-pandemic levels in June 2020 – December 2020.
Conclusion: There was significantly reduced public interest in both common malignancies and cancer screening methods at the beginning of the COVID-19 pandemic in the United States. However, after an
initial decline, public interest as indicated by Google search volumes quickly returned to pre-pandemic levels in the second half of the calendar year 2020. In addition, trends in public interest in cancer screening
as indicated by Google search volumes aligned with cancer screening uptake rates in the United States during the study period. This finding suggests that Google Trends may serve as an effective tool in gauging
the public’s interest in cancer and/or cancer screenings in the United States, which makes it a valuable resource that can be used to inform decisions aimed at improving cancer screening rates in the future.
Relevance for Patients: The Google Trends tool can be used to measure public interest in various malignancies and their associated screening methods. Google Trends data may be used to inform measures
aimed at improving cancer screening uptake.
[1] Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak; 2021. Available from: https://www.whitehouse.gov/presidential-actions/proclamation-declaring-nationalemergency-concerning-novel-coronavirus-disease-covid19-outbreak [Last accessed on 2021 Jun 18].
[2] Non-Emergent, Elective Medical Services, and Treatment Recommendations; 2021. Available from: https://www.cms.gov/files/document/cms-non-emergent-electivemedical-recommendations.pdf [Last accessed on 2021 Jul 19].
[3] McCabe R, Schmit N, Christen P. Adapting Hospital Capacity to Meet Changing Demands during the COVID-19 Pandemic. BMC Med 2020;18:329.
[4] Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of Cancer Screening Deficit in the United States with the COVID-19 Pandemic. JAMA Oncol 2020;7:878-84.
[5] Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, et al. The Impact of the COVID-19 Pandemic on Cancer Deaths Due to Delays in Diagnosis in England, UK: A National, Population-Based, Modelling Study. Lancet Oncol 2020;21:1023-34.
[6] Patt D, Gordan L, Diaz M, Okon T, Grady L, Harmison M, et al. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clin Cancer Inform 2020;4:1059-71.
[7] Alkatout I, Biebl M, Momenimovahed Z, Giovannucci E, Hadavandsiri F, Salehiniya H, et al. Has COVID-19 Affected Cancer Screening Programs? A Systematic Review. Front Oncol 2021;11:675038.
[8] Osei E, Francis R, Mohamed A, Sheraz L, Soltani-Mayvan F. Impact of COVID-19 Pandemic on the Oncologic Care Continuum: Urgent Need to Restore Patients Care to PreCOVID-19 Era. J Radiother Pract 2021:1-11.
[9] Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The Impact of the COVID-19 Pandemic on Cancer Care. Nat Cancer 2020;1:565-7.
[10] Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE. Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis. Urology 2020;139:64-70.
[11] Search Engine Market Share Worldwide. In: StatCounter Global Stats; 2021. Available from: https://www.gs.statcounter.com/search-engine-market-share [Last accessed on 2021 Jul 12].
[12] Kang M, Zhong H, He J, Rutherford S, Yang F. Using Google Trends for Influenza Surveillance in South China. PLoS One 2013;8:e55205.
[13] Cohen SA, Zhuang T, Xiao M, Michaud JB, Shapiro L, Kamal RN. Using Google Trends Data to Track Healthcare Use for Hand Osteoarthritis. Cureus 2021;13:e13786.
[14] Cohen SA, Cohen LE, Tijerina JD, Bouz G, Lefebvre R, Stevanovic M, et al. Google Trends as a Tool for Evaluating Public Interest in Total Knee Arthroplasty and Total Hip Arthroplasty. J Clin Transl Res 2021;7:456-66.
[15] Tijerina JD, Morrison SD, Nolan IT, Vail DG, Nazerali R, Lee GK. Google Trends as a Tool for Evaluating Public Interest in Facial Cosmetic Procedures. Aesthet Surg J 2019;39:908-18.
[16] Tijerina JD, Cohen SA, Parham MJ, Debbaut C, Cohen L, Stevanovic M, et al. Public Interest in Elective Orthopedic Surgery Following Recommendations During COVID-19: A Google Trends Analysis. Cureus 2020;12:e12123.
[17] Cohen SA, Zhuang T, Xiao M, Michaud J, Amanatullah DF, Kamal RN. Google Trend Analysis Shows Increasing Public Interest in Platelet-Rich Plasma Injections for Hip and Knee Osteoarthritis. J Arthroplasty 2021;36:3616-22.
[18] Cohen SA, Cohen LE, Tijerina JD. The Impact of Monthly Campaigns and Other High-Profile Media Coverage on Public Interest in 13 Malignancies: A Google Trends Analysis. Ecancer 2020;14:1154.
[19] Vasconcellos-Silva PR, Carvalho DB, Trajano V, de La Rocque LR, Sawada AC, Juvanhol LL. Using Google Trends Data to Study Public Interest in Breast Cancer Screening in Brazil: Why Not a Pink February? JMIR Public Health Surveill 2017;3:e17.
[20] FAQ About Google Trends Data-Trends Help; 2021. Available from: https://www.support.google.com/trends/answer/4365533?hl=en [Last accessed on 2021 Jul 17]. [21] Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc B 1995;57:289-300.
[22] Xu C, Wang Y, Yang H, Hou J, Sun L, Zhang X, et al. Association between Cancer Incidence and Mortality in Web-Based Data in China: Infodemiology Study. J Med Internet Res 2019;21:e10677.
[23] Phillips CA, Barz Leahy A, Li Y, Schapira MM, Bailey LC, et al. Relationship Between State-Level Google Online Search Volume and Cancer Incidence in the United States: Retrospective Study. J Med Internet Res 2018;20:e6.
[24] Mohamad M, Kok HS. Using Google Trends Data to Study Public Interest in Breast Cancer Screening in Malaysia. Asian Pac J Cancer Prev 2019;20:1427-32.
[25] Quintanilha LF, Souza LN, Sanches D, Fukutani KF. The Impact of Cancer Campaigns in Brazil: A Google Trends Analysis. Ecancer 2019;13:963.
[26] Xu R, Brown P, Baxter N, Sawka AM. Online Public Interest in Cancer during the COVID-19 Pandemic. JCO Clin Cancer Inform 2021;5:695-700.
[27] Wong LE, Hawkins JE, Langness S, Murrell KL, Iris P, Sammann A. Where Are All the Patients? Addressing COVID-19 Fear to Encourage Sick Patients to Seek Emergency Care. NEJM Catal Innov Care Deliv 2020:1-12.
[28] Czeisler MÉ. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns-United States. MMWR Morb Mortal Wkly Rep 2020;69:1250-7.
[29] Findling MG, Blendon RJ, Benson JM. Delayed Care with Harmful Health Consequences-Reported Experiences from National Surveys during Coronavirus Disease 2019. JAMA Health Forum 2020;1:e201463.
[30] Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities. JMIR Cancer 2020;6:e21697.
[31] Perin DM, Christensen T, Burón A, Haas JS, Kamineni A, Pashayan N, et al. Interruption of Cancer Screening Services Due to COVID-19 Pandemic: Lessons from Previous Disasters. Prev Med Rep 2021;23:101399.
[32] Metcalfe D, Price C, Powell J. Media Coverage and Public Reaction to a Celebrity Cancer Diagnosis. J Public Health 2011;33:80-5.
[33] Jaklevic MC. Pandemic Spotlights In-Home Colon Cancer Screening Tests. JAMA 2021;325:116-8.
[34] Gorin SN, Jimbo M, Heizelman R, Harmes KM, HarperDM. The Future of Cancer Screening after COVID-19 May be at Home. Cancer 2021;127:498-503.
[35] Caleia AI, Pires C, de Fátima Pereira J, Pinto-Ribeiro F, Longatto-Filho A. Self-Sampling as a Plausible Alternative to Screen Cervical Cancer Precursor Lesions in a Population with Low Adherence to Screening: A Systematic Review. Acta Cytol 2020;64:332-43.
[36] Young B, Bedford L, Kendrick D, Vedhara K, Robertson JF, das Nair R. Factors Influencing the Decision to Attend Screening for Cancer in the UK: A Meta-Ethnography of Qualitative Research. J Public Health 2018;40:315-39.
[37] Bennett KF, Waller J, Chorley AJ, Ferrer RA, Haddrell JB, Marlow LA. Barriers to Cervical Screening and Interest in Self-Sampling among Women Who Actively Decline Screening. J Med Screen 2018;25:211-7.
[38] Reynolds LM, Bissett IP, Consedine NS. Emotional Predictors of Bowel Screening: The Avoidance-Promoting Role of Fear, Embarrassment, and Disgust. BMC Cancer 2018;18:518.
[39] McBain RK, Cantor JH, Jena AB, Pera MF, Bravata DM, Whaley CM. Decline and Rebound in Routine Cancer Screening Rates during the COVID-19 Pandemic. J Gen Intern Med 2021;36:1829-31.
[40] Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of COVID-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med 2021;385:585-94.